TCL Archive FDA approval of two colon cancer therapies triggers discussion among researchers, clinicians about best treatment and clinical trial designs. CMS reimbursement pending; costs to U.S. of the new drugs could be billions per year, but some predict dramatic increases in survival. March 5, 2004
TCL Archive President Asks $989.3 Million fr NCI, But Mistake In Grant Allocations May Lead To Additional Money February 4, 1983
TCL Archive New: Special Reports on the Dialogue and NCI’s 2015 goal posted at cancerletter.com. August 8, 2003
